(Q33516585)

27 July 2017

title

Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data (English)

1 reference

27 July 2017

1 reference

Agnès Poirier

1

1 reference

27 July 2017

Anne-Christine Cascais

series ordinal

2

1 reference

27 July 2017

Christoph Funk

series ordinal

3

1 reference

27 July 2017

Thierry Lavé

series ordinal

4

1 reference

27 July 2017

publication date

20 November 2009

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

27 July 2017

published in

1 reference

27 July 2017

volume

36

1 reference

27 July 2017

issue

6

1 reference

27 July 2017

page(s)

585-611

1 reference

Uptake of teicoplanin by isolated rat hepatocytes: comparison with in vivo hepatic distribution

27 July 2017

cites work

1 reference

12 December 2020

Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model

1 reference

12 December 2020

A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes

1 reference

12 December 2020

Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats.

1 reference

12 December 2020

Interspecies scaling of biliary excreted drugs

1 reference

12 December 2020

Membrane transport as a determinant of the hepatic elimination of drugs and metabolites

1 reference

12 December 2020

Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans

1 reference

12 December 2020

Protein binding in plasma of valsartan, a new angiotensin II receptor antagonist

1 reference

12 December 2020

Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.

1 reference

12 December 2020

In vitro-in vivo correlation of hepatobiliary drug clearance in humans.

1 reference

12 December 2020

Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes

1 reference

12 December 2020

In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance

1 reference

12 December 2020

Interspecies pharmacokinetic comparisons and allometric scaling of napsagatran, a low molecular weight thrombin inhibitor

1 reference

12 December 2020

Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes

1 reference

12 December 2020

Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system

1 reference

12 December 2020

Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics

1 reference

12 December 2020

Hepatocyte suspensions and cultures as tools in experimental carcinogenesis

1 reference

12 December 2020

Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family

1 reference

12 December 2020

In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in sandwich-cultured rat hepatocytes: comparison with in vivo biliary clearance.

1 reference

12 December 2020

Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes

1 reference

12 December 2020

Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation

1 reference

12 December 2020

An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery.

1 reference

12 December 2020

Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.

1 reference

12 December 2020

Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance

1 reference

12 December 2020

Absolute difference of hepatobiliary transporter multidrug resistance-associated protein (MRP2/Mrp2) in liver tissues and isolated hepatocytes from rat, dog, monkey, and human.

1 reference

12 December 2020

Extensive biliary excretion of the sulfasalazine analogue, susalimod, but different concentrations in the bile duct in various animal species correlating to species-specific hepatobiliary toxicity

1 reference

12 December 2020

Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions

1 reference

12 December 2020

Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam.

1 reference

12 December 2020

1 reference

12 December 2020

Challenges and opportunities with modelling and simulation in drug discovery and drug development

1 reference

12 December 2020

Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver

1 reference

12 December 2020

Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes

1 reference

12 December 2020

Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro

1 reference

12 December 2020

Hepatic canalicular membrane. Introduction: transport across the hepatocyte canalicular membrane

1 reference

12 December 2020

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

1 reference

12 December 2020

Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes

1 reference

12 December 2020

Valsartan. A review of its pharmacology and therapeutic use in essential hypertension

1 reference

12 December 2020

Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes.

1 reference

12 December 2020

Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria

1 reference

12 December 2020

A novel strategy for physiologically based predictions of human pharmacokinetics

1 reference

12 December 2020

The role of hepatic transporters in drug elimination

1 reference

12 December 2020

Use of canalicular membrane vesicles (CMVs) from rats, dogs, monkeys and humans to assess drug transport across the canalicular membrane

1 reference

12 December 2020

Misuse of the well-stirred model of hepatic drug clearance.

1 reference

12 December 2020

Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes

1 reference

12 December 2020

Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases.

1 reference

12 December 2020

Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine

1 reference

12 December 2020

Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose

1 reference

12 December 2020

Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo

1 reference

12 December 2020

Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man

1 reference

12 December 2020

Recent progresses in the experimental methods and evaluation strategies of transporter functions for the prediction of the pharmacokinetics in humans

1 reference

12 December 2020

Hepatic bile entry into and transit pattern within the gallbladder lumen: a new quantitative cholescintigraphic technique for measurement of its concentration function.

1 reference

12 December 2020

Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.

1 reference

12 December 2020

Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril

1 reference

12 December 2020

Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs

1 reference

12 December 2020

Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmacokinetics to man

1 reference

12 December 2020

Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans

1 reference

12 December 2020

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

1 reference

12 December 2020

10.1007/S10928-009-9139-3

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

1024218284

0 references

1 reference